{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:57:38Z","timestamp":1781153858161,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Malaysian Ministry of Education Fundamental Research Grant Scheme","award":["FRGS\/1\/2018\/SKK08\/UM\/01\/1"],"award-info":[{"award-number":["FRGS\/1\/2018\/SKK08\/UM\/01\/1"]}]},{"name":"ALS Association Seed Grant","award":["IF091-2022"],"award-info":[{"award-number":["IF091-2022"]}]},{"name":"ALS Association Seed Grant","award":["IF095-2023"],"award-info":[{"award-number":["IF095-2023"]}]},{"name":"Sydney Southeast Asia Centre Collaborative Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-024-00798-0","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T01:37:19Z","timestamp":1736732239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ATXN2 polyglutamine intermediate repeats length expansions in Malaysian patients with amyotrophic lateral sclerosis (ALS)"],"prefix":"10.1007","volume":"26","author":[{"given":"Suzanna","family":"Edgar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurul Angelyn","family":"Zulhairy-Liong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melina","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchi","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey Ochieng","family":"Odongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khean-Jin","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Paul","family":"Capelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nortina","family":"Shahrizaila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina L.","family":"Kennerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azlina","family":"Ahmad-Annuar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"16","key":"798_CR1","first-page":"1602","volume":"377","author":"RHJ Brown","year":"2017","unstructured":"Brown RHJ, Al-Chalabi A (2017) Amyotroph Lateral Scler N Engl J Med 377(16):1602","journal-title":"Amyotroph Lateral Scler N Engl J Med"},{"issue":"6","key":"798_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/jnnp.2010.224501","volume":"82","author":"S Byrne","year":"2011","unstructured":"Byrne S et al (2011) Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 82(6):623\u2013627","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"798_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","volume":"13","author":"A Al-Chalabi","year":"2017","unstructured":"Al-Chalabi A, van den Berg LH, Veldink J (2017) Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol 13(2):96\u2013104","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"798_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA et al (2022) Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol 21(5):465\u2013479","journal-title":"Lancet Neurol"},{"issue":"7","key":"798_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/14737159.2020.1779060","volume":"20","author":"B Perrone","year":"2020","unstructured":"Perrone B, Conforti FL (2020) Common mutations of interest in the diagnosis of amyotrophic lateral sclerosis: how common are common mutations in ALS genes? Expert Rev Mol Diagn 20(7):703\u2013714","journal-title":"Expert Rev Mol Diagn"},{"issue":"9","key":"798_CR6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/humu.22157","volume":"33","author":"O Abel","year":"2012","unstructured":"Abel O et al (2012) ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum Mutat 33(9):1345\u20131351","journal-title":"Hum Mutat"},{"issue":"12","key":"798_CR7","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41588-021-00973-1","volume":"53","author":"W van Rheenen","year":"2021","unstructured":"van Rheenen W et al (2021) Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet 53(12):1636\u20131648","journal-title":"Nat Genet"},{"issue":"7","key":"798_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","volume":"88","author":"ZY Zou","year":"2017","unstructured":"Zou ZY et al (2017) Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 88(7):540\u2013549","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"798_CR9","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1212\/NXG.0000000000000299","volume":"4","author":"SM Pulst","year":"2018","unstructured":"Pulst SM (2018) The complex structure of ATXN2 genetic variation. Neurol Genet 4(6):e299","journal-title":"Neurol Genet"},{"issue":"7310","key":"798_CR10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden AC et al (2010) Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466(7310):1069\u20131075","journal-title":"Nature"},{"key":"798_CR11","doi-asserted-by":"publisher","first-page":"178e1","DOI":"10.1016\/j.neurobiolaging.2016.11.010","volume":"51","author":"W Sproviero","year":"2017","unstructured":"Sproviero W et al (2017) ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol Aging 51:178e1\u2013178e9","journal-title":"Neurobiol Aging"},{"issue":"4","key":"798_CR12","doi-asserted-by":"publisher","first-page":"e1005182","DOI":"10.1371\/journal.pgen.1005182","volume":"11","author":"W Dansithong","year":"2015","unstructured":"Dansithong W et al (2015) Ataxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse model. PLoS Genet 11(4):e1005182","journal-title":"PLoS Genet"},{"issue":"4","key":"798_CR13","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.cell.2018.03.025","volume":"173","author":"K Zhang","year":"2018","unstructured":"Zhang K et al (2018) Stress Granule Assembly disrupts nucleocytoplasmic transport. Cell 173(4):958\u2013971e17","journal-title":"Cell"},{"issue":"3","key":"798_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s12031-011-9548-9","volume":"45","author":"NM Bonini","year":"2011","unstructured":"Bonini NM, Gitler AD (2011) Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS. J Mol Neurosci 45(3):676\u2013683","journal-title":"J Mol Neurosci"},{"issue":"4","key":"798_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/hmg\/dds479","volume":"22","author":"MA Farg","year":"2013","unstructured":"Farg MA et al (2013) Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis. Hum Mol Genet 22(4):717\u2013728","journal-title":"Hum Mol Genet"},{"issue":"11","key":"798_CR16","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41431-022-01146-2","volume":"30","author":"K Salmon","year":"2022","unstructured":"Salmon K et al (2022) The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis. Eur J Hum Genet 30(11):1205\u20131207","journal-title":"Eur J Hum Genet"},{"key":"798_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neurobiolaging.2021.07.008","volume":"108","author":"S Edgar","year":"2021","unstructured":"Edgar S et al (2021) Mutation analysis of SOD1, C9orf72, TARDBP and FUS genes in ethnically-diverse Malaysian patients with amyotrophic lateral sclerosis (ALS). Neurobiol Aging 108:200\u2013206","journal-title":"Neurobiol Aging"},{"issue":"1","key":"798_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/17482960802521126","volume":"10","author":"MD Carvalho","year":"2009","unstructured":"Carvalho MD, Swash M (2009) Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler 10(1):53\u201357","journal-title":"Amyotroph Lateral Scler"},{"issue":"5","key":"798_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293\u2013299","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"798_CR20","doi-asserted-by":"publisher","first-page":"811202","DOI":"10.3389\/fneur.2022.811202","volume":"13","author":"X Hou","year":"2022","unstructured":"Hou X et al (2022) The clinical and polynucleotide repeat expansion analysis of ATXN2, NOP56, AR and C9orf72 in patients with ALS from Mainland China. Front Neurol 13:811202","journal-title":"Front Neurol"},{"issue":"9","key":"798_CR21","doi-asserted-by":"publisher","first-page":"2236e5","DOI":"10.1016\/j.neurobiolaging.2013.04.009","volume":"34","author":"X Liu","year":"2013","unstructured":"Liu X et al (2013) ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging 34(9):2236e5\u20132236e8","journal-title":"Neurobiol Aging"},{"key":"798_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neurobiolaging.2021.06.008","volume":"107","author":"Z Liu","year":"2021","unstructured":"Liu Z et al (2021) Mutation spectrum of amyotrophic lateral sclerosis in Central South China. Neurobiol Aging 107:181\u2013188","journal-title":"Neurobiol Aging"},{"issue":"3","key":"798_CR23","doi-asserted-by":"publisher","first-page":"1603e11","DOI":"10.1016\/j.neurobiolaging.2014.10.015","volume":"36","author":"HP Lu","year":"2015","unstructured":"Lu HP et al (2015) Intermediate-length polyglutamine in ATXN2 is a possible risk factor among Eastern Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging, 36(3): p. 1603 e11- 1603e14","journal-title":"Neurobiol Aging"},{"issue":"2","key":"798_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/hmg\/11.2.153","volume":"11","author":"A Errico","year":"2002","unstructured":"Errico A, Ballabio A, Rugarli EI (2002) Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum Mol Genet 11(2):153\u2013163","journal-title":"Hum Mol Genet"},{"issue":"2","key":"798_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/ejhg.2008.147","volume":"17","author":"M Shoukier","year":"2009","unstructured":"Shoukier M et al (2009) Expansion of mutation spectrum, determination of mutation cluster regions and predictive structural classification of SPAST mutations in hereditary spastic paraplegia. Eur J Hum Genet 17(2):187\u2013194","journal-title":"Eur J Hum Genet"},{"issue":"S1","key":"798_CR26","first-page":"e2021220","volume":"92","author":"L Verriello","year":"2021","unstructured":"Verriello L et al (2021) Amplifying the spectrum of SPAST gene mutations. Acta Biomed 92(S1):e2021220","journal-title":"Acta Biomed"},{"issue":"1","key":"798_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12920-024-01807-9","volume":"17","author":"ZF Nagy","year":"2024","unstructured":"Nagy ZF et al (2024) Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations. BMC Med Genomics 17(1):30","journal-title":"BMC Med Genomics"},{"issue":"5","key":"798_CR28","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ajhg.2021.03.011","volume":"108","author":"C Depienne","year":"2021","unstructured":"Depienne C, Mandel JL (2021) 30 years of repeat expansion disorders: what have we learned and what are the remaining challenges? Am J Hum Genet 108(5):764\u2013785","journal-title":"Am J Hum Genet"},{"key":"798_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neurobiolaging.2019.12.024","volume":"88","author":"U Shamim","year":"2020","unstructured":"Shamim U et al (2020) C9orf72 hexanucleotide repeat expansion in Indian patients with ALS: a common founder and its geographical predilection. Neurobiol Aging 88:156 e1-156 e9","journal-title":"Neurobiol Aging"},{"issue":"10","key":"798_CR30","doi-asserted-by":"publisher","first-page":"2423e1","DOI":"10.1016\/j.neurobiolaging.2014.05.008","volume":"35","author":"BW Soong","year":"2014","unstructured":"Soong BW et al (2014) Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 35(10):2423e1\u20132423e6","journal-title":"Neurobiol Aging"},{"key":"798_CR31","doi-asserted-by":"publisher","first-page":"201e5","DOI":"10.1016\/j.neurobiolaging.2018.03.019","volume":"67","author":"YE Kim","year":"2018","unstructured":"Kim YE et al (2018) Analysis of ATXN2 trinucleotide repeats in Korean patients with amyotrophic lateral sclerosis. Neurobiol Aging, 67: p. 20 1e5-201e8","journal-title":"Neurobiol Aging"},{"issue":"2","key":"798_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10048-019-00570-9","volume":"20","author":"H Naruse","year":"2019","unstructured":"Naruse H et al (2019) Association of ATXN2 intermediate-length CAG repeats with amyotrophic lateral sclerosis correlates with the distributions of normal CAG repeat alleles among individual ethnic populations. Neurogenetics 20(2):65\u201371","journal-title":"Neurogenetics"},{"key":"798_CR33","doi-asserted-by":"crossref","unstructured":"Narain P et al (2017) C9orf72 hexanucleotide repeat expansions and ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis. Neurobiol Aging, 56: p. 211 e9-211 e14.","DOI":"10.1016\/j.neurobiolaging.2017.04.011"},{"issue":"3","key":"798_CR34","doi-asserted-by":"publisher","first-page":"e17951","DOI":"10.1371\/journal.pone.0017951","volume":"6","author":"Z Yu","year":"2011","unstructured":"Yu Z et al (2011) PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats. PLoS ONE 6(3):e17951","journal-title":"PLoS ONE"},{"issue":"4","key":"798_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00439-011-1000-2","volume":"130","author":"L Corrado","year":"2011","unstructured":"Corrado L et al (2011) ATXN-2 CAG repeat expansions are interrupted in ALS patients. Hum Genet 130(4):575\u2013580","journal-title":"Hum Genet"},{"issue":"1","key":"798_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.nbd.2011.08.021","volume":"45","author":"S Gispert","year":"2012","unstructured":"Gispert S et al (2012) The modulation of amyotrophic lateral sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect. Neurobiol Dis 45(1):356\u2013361","journal-title":"Neurobiol Dis"},{"issue":"24","key":"798_CR37","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1212\/WNL.0b013e31821f445b","volume":"76","author":"P Van Damme","year":"2011","unstructured":"Van Damme P et al (2011) Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 76(24):2066\u20132072","journal-title":"Neurology"},{"issue":"4","key":"798_CR38","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41431-020-00767-9","volume":"29","author":"R Borg","year":"2021","unstructured":"Borg R et al (2021) Genetic analysis of ALS cases in the isolated island population of Malta. Eur J Hum Genet 29(4):604\u2013614","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"798_CR39","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1212\/NXG.0000000000000283","volume":"4","author":"M Tojima","year":"2018","unstructured":"Tojima M et al (2018) Homozygous 31 trinucleotide repeats in the SCA2 allele are pathogenic for cerebellar ataxia. Neurol Genet 4(6):e283","journal-title":"Neurol Genet"},{"issue":"12","key":"798_CR40","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jamaneurol.2014.2082","volume":"71","author":"AG Neuenschwander","year":"2014","unstructured":"Neuenschwander AG et al (2014) Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis. JAMA Neurol 71(12):1529\u20131534","journal-title":"JAMA Neurol"},{"issue":"Pt 9","key":"798_CR41","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1093\/brain\/awv178","volume":"138","author":"JM Solowska","year":"2015","unstructured":"Solowska JM, Baas PW (2015) Hereditary spastic paraplegia SPG4: what is known and not known about the disease. Brain 138(Pt 9):2471\u20132484","journal-title":"Brain"},{"issue":"12","key":"798_CR42","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1093\/brain\/awy285","volume":"141","author":"L Parodi","year":"2018","unstructured":"Parodi L et al (2018) Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex. Brain 141(12):3331\u20133342","journal-title":"Brain"},{"issue":"10","key":"798_CR43","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/jnnp.2009.201103","volume":"81","author":"ST de Bot","year":"2010","unstructured":"de Bot ST et al (2010) Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations. J Neurol Neurosurg Psychiatry 81(10):1073\u20131078","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"798_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11910-021-01099-x","volume":"21","author":"L Saputra","year":"2021","unstructured":"Saputra L, Kumar KR (2021) Challenges and controversies in the genetic diagnosis of Hereditary Spastic Paraplegia. Curr Neurol Neurosci Rep 21(4):15","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1\u20132","key":"798_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2012.07.036","volume":"321","author":"TT Nielsen","year":"2012","unstructured":"Nielsen TT et al (2012) ATXN2 with intermediate-length CAG\/CAA repeats does not seem to be a risk factor in hereditary spastic paraplegia. J Neurol Sci 321(1\u20132):100\u2013102","journal-title":"J Neurol Sci"},{"issue":"8","key":"798_CR46","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/brain\/awac167","volume":"145","author":"JD Glass","year":"2022","unstructured":"Glass JD et al (2022) ATXN2 intermediate expansions in amyotrophic lateral sclerosis. Brain 145(8):2671\u20132676","journal-title":"Brain"},{"issue":"18supplement","key":"798_CR47","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1212\/WNL.98.18_supplement.712","volume":"98","author":"A Chio","year":"2022","unstructured":"Chio A et al (2022) Deciphering the phenotype of ALS patients with intermediate ATXN2 PolyQ expansion (S11.003). Neurology 98(18supplement):712\u2013p","journal-title":"Neurology"},{"issue":"6","key":"798_CR48","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1034\/j.1399-0004.2002.620610.x","volume":"62","author":"Y Zhao","year":"2002","unstructured":"Zhao Y et al (2002) Prevalence and ethnic differences of autosomal-dominant cerebellar ataxia in Singapore. Clin Genet 62(6):478\u2013481","journal-title":"Clin Genet"},{"key":"798_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40673-020-00120-2","volume":"7","author":"NM Ibrahim","year":"2020","unstructured":"Ibrahim NM et al (2020) Frequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia. Cerebellum Ataxias 7:11","journal-title":"Cerebellum Ataxias"},{"issue":"2","key":"798_CR50","doi-asserted-by":"publisher","first-page":"2100078","DOI":"10.1002\/ggn2.202100078","volume":"3","author":"P Sharma","year":"2022","unstructured":"Sharma P et al (2022) Genetics of Ataxias in Indian Population: a collative insight from a Common Genetic Screening Tool. Adv Genet (Hoboken) 3(2):2100078","journal-title":"Adv Genet (Hoboken)"},{"issue":"2","key":"798_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s004390000240","volume":"106","author":"Q Saleem","year":"2000","unstructured":"Saleem Q et al (2000) Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: high frequency of SCA2 and evidence for a common founder mutation. Hum Genet 106(2):179\u2013187","journal-title":"Hum Genet"},{"key":"798_CR52","doi-asserted-by":"publisher","first-page":"1177431","DOI":"10.3389\/fnins.2023.1177431","volume":"17","author":"QQ Duan","year":"2023","unstructured":"Duan QQ et al (2023) Risk factors of amyotrophic lateral sclerosis: a global meta-summary. Front Neurosci 17:1177431","journal-title":"Front Neurosci"},{"issue":"11","key":"798_CR53","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S1474-4422(14)70219-4","volume":"13","author":"A Al-Chalabi","year":"2014","unstructured":"Al-Chalabi A et al (2014) Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol 13(11):1108\u20131113","journal-title":"Lancet Neurol"},{"issue":"15","key":"798_CR54","doi-asserted-by":"publisher","first-page":"e1657","DOI":"10.1212\/WNL.0000000000009015","volume":"94","author":"S Vucic","year":"2020","unstructured":"Vucic S et al (2020) ALS is a multistep process in South Korean, Japanese, and Australian patients. Neurology 94(15):e1657\u2013e1663","journal-title":"Neurology"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-024-00798-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-024-00798-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-024-00798-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T05:01:57Z","timestamp":1769403717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-024-00798-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["798"],"URL":"https:\/\/doi.org\/10.1007\/s10048-024-00798-0","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}